Moreover, macro_FABP4 alveolar macrophages were reported to be significantly elevated in post-treatment NSCLC patients who received neoadjuvant PD-1 blockade combined with chemotherapy (Hu et al., 2023). The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.